Published in Clin Exp Immunol on December 01, 1985
In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol (1996) 1.39
IL-1 and IFN-gamma increase vascular permeability. Immunology (1988) 1.29
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis (1991) 1.20
Human endothelial cells: effect of TNF-alpha on peripheral blood mononuclear cell adhesion. Immunology (1991) 1.19
Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1. Immunology (1988) 1.17
Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells. J Clin Invest (1987) 1.14
Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin Exp Immunol (1992) 1.13
Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunology (2000) 1.05
The recruitment of lymphocytes into the skin by T cell lymphokines: the role of gamma-interferon. Clin Exp Immunol (1988) 1.02
Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. J Clin Invest (1991) 0.99
T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells. Immunology (1990) 0.96
Cellular responses to human chondrocytes: absence of allogeneic responses in the presence of HLA-DR and ICAM-1. Clin Exp Immunol (1992) 0.89
The endothelium: its role in scleroderma. Ann Rheum Dis (1991) 0.89
Preferential binding of monocytes and Leu 2+ T lymphocytes to interferon-gamma treated cultured skin endothelial cells and keratinocytes. Arch Dermatol Res (1988) 0.88
Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cells. Immunology (1988) 0.86
Interferon-gamma modulates messenger RNA levels of c-sis (PDGF-B chain), PDGF-A chain, and IL-1 beta genes in human vascular endothelial cells. Am J Pathol (1989) 0.86
Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cells. Clin Exp Immunol (1990) 0.86
Effect of cytokine-induced soluble ICAM-1 from human synovial cells on synovial cell-lymphocyte adhesion. Clin Exp Immunol (1994) 0.86
Mechanisms of lymphocyte adhesion to endothelial cells: studies using a LFA-1-deficient cell line. Immunology (1989) 0.84
Effects of anti-rheumatic herbal medicines on cellular adhesion molecules. Ann Rheum Dis (1999) 0.84
The effects of interferon on the recirculation of lymphocytes in the rat. Immunology (1987) 0.83
Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayers. Clin Exp Immunol (1989) 0.83
Adhesion and penetration properties of human lymphocytes acting on allogeneic vascular endothelial cells. Immunology (1994) 0.82
Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin Exp Immunol (1992) 0.81
Kinetics of MHC gene expression and mRNA synthesis in brain endothelium. Immunology (1988) 0.81
Enhanced adhesion of autologous lymphocytes to gamma-interferon-treated human endothelial cells in vitro. Br J Exp Pathol (1989) 0.81
Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol (2014) 0.80
Interferon-gamma-increased adherence of lymphocytes to high endothelial venules. Immunology (1989) 0.79
Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s. Trans Am Clin Climatol Assoc (1991) 0.78
Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis. Ann Rheum Dis (1991) 0.76
Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals. Clin Exp Immunol (1990) 0.76
Lymphocyte traffic, endothelium, and rheumatoid arthritis. Ann Rheum Dis (1987) 0.75
Essential pathogenic role for endogenous interferon-gamma (IFN-gamma) during disease onset phase of murine experimental autoimmune orchitis. I. In vivo studies. Clin Exp Immunol (1998) 0.75
THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT. Proc R Soc Lond B Biol Sci (1964) 20.20
The recirculation of lymphocytes from blood to lymph in the rat. J Physiol (1959) 7.09
THE MIGRATION OF LYMPHOCYTES THROUGH THE ENDOTHELIUM OF VENULES IN LYMPH NODES: AN ELECTRON MICROSCOPE STUDY. Proc R Soc Lond B Biol Sci (1964) 6.93
Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16
Activated macrophages induce vascular proliferation. Nature (1977) 3.74
Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science (1965) 3.40
Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol (1981) 2.18
Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol (1975) 2.09
The migration of cells through chronically inflamed tissues. J Pathol (1970) 1.92
Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum (1983) 1.88
Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med (1975) 1.82
Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins. J Clin Invest (1980) 1.71
Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration. Eur J Immunol (1983) 1.62
An electron microscopic study of leukocyte emigration and vascular permeability in tuberculin sensitivity. Am J Pathol (1967) 1.53
The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages. J Cell Physiol (1978) 1.35
Interferon production in mixed lymphocyte cell cultures. Infect Immun (1971) 1.34
Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunology (1976) 1.31
An in vitro model of lymphocyte homing. I. Characterization of the interaction between thoracic duct lymphocytes and specialized high-endothelial venules of lymph nodes. J Immunol (1977) 1.27
Peroxidase arthritis. II. Lymphoid cell-endothelial interactions during a developing immunologic inflammatory response. Am J Pathol (1972) 1.22
Migration inhibition of endothelial cells by lymphokine-containing supernatants. Science (1982) 1.05
Endothelium-lymphocyte interactions in vitro. II. Adherence of allergized lymphocytes. Cell Immunol (1979) 0.93
The small blood vessels in areas of lymphocytic infiltration around malignant neoplasms. Br J Cancer (1982) 0.89
Quantitative assessment of the adherence of normal human blood mononuclear cells to vascular endothelial cell monolayers. Cell Immunol (1982) 0.85
Endothelial specialization of salivary gland vessels for accelerated lymphocyte transfer in Sjögren's syndrome. J Rheumatol (1983) 0.84
In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest (1968) 4.01
Generation of single optical plasmons in metallic nanowires coupled to quantum dots. Nature (2007) 3.50
Lymphokine stimulation of collagen accumulation. J Clin Invest (1976) 2.94
The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum (1966) 2.83
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ (1997) 2.63
Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology (1975) 2.62
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol (1990) 2.55
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum (1974) 2.45
Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med (1973) 2.38
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Production of interleukin 1 by human endothelial cells. J Immunol (1986) 2.27
Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27
Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26
Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet (1966) 2.19
Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum (1976) 2.18
Association of maternal endothelial dysfunction with preeclampsia. JAMA (2001) 2.17
IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol (1990) 2.15
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol (1992) 2.12
Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum (1975) 2.09
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane. Clin Exp Immunol (1969) 2.00
Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res (1997) 1.97
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol (1990) 1.86
The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids. Science (1989) 1.86
Improved method of hexosamine determination. Anal Biochem (1971) 1.84
Selective release of histamine from rat mast cells by compound 48-80 and anitgen. Am J Physiol (1969) 1.81
Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis (1985) 1.79
Anomalous zero-bias conductance peak in a Nb-InSb nanowire-Nb hybrid device. Nano Lett (2012) 1.79
Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum (1976) 1.75
Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol (1987) 1.73
Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. Peptides (1984) 1.72
Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins. J Clin Invest (1980) 1.71
Negative result: treatment of patients with rheumatoid arthritis with gamma globulin: a double-blind controlled study. Arthritis Rheum (1969) 1.63
Spontaneous rupture of the spleen in rheumatoid arthritis. Ann Rheum Dis (1983) 1.63
Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol (1991) 1.57
Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57
Lymphocyte chemotactic activity of human interleukin 1. J Immunol (1984) 1.56
Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase. J Clin Invest (1977) 1.55
Immunoglobulin and specific antibody synthesis in a chronic inflammatory focus: antigen-induced synovitis. J Immunol (1969) 1.52
Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med (1994) 1.51
Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest (1993) 1.50
Studies of isolated synovial living cells of rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum (1971) 1.49
Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol (1986) 1.46
Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med (1968) 1.45
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest (1969) 1.43
Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum (1997) 1.42
Mechanisms of inflammation in gout. Rheumatology (Oxford) (2005) 1.42
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum (1973) 1.41
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol (1986) 1.41
Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol (2001) 1.41
Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep (2001) 1.40
IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum (1983) 1.39
Enthesopathy in a case of primary biliary cirrhosis with positive HLA-B27. Clin Exp Rheumatol (1998) 1.38
Effect of a gold salt on the immune response. Arthritis Rheum (1967) 1.38
Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci U S A (1985) 1.37
Viruses and the connective tissue diseases. Ann Intern Med (1971) 1.37
The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol (1991) 1.37
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum (1974) 1.34
Brain structural mapping using a novel hybrid implicit/explicit framework based on the level-set method. Neuroimage (2005) 1.33
Tailgut cyst: diagnosis with CT and sonography. AJR Am J Roentgenol (1986) 1.32
Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation (2001) 1.32
Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron (2000) 1.31
The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice. J Immunol (1982) 1.31
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum (1972) 1.31
Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. J Clin Invest (1981) 1.31
Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant (1991) 1.30
Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol (1999) 1.30
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum (1986) 1.30
Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surface IgM to IgD. J Immunol (1978) 1.29
Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology (2000) 1.29
Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest (1986) 1.29
Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice. Clin Exp Immunol (1971) 1.28
Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum (1981) 1.26
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest (1977) 1.26
Degradation of immunoglobulins by intracellular proteases in the range of neutral pH. J Immunol (1970) 1.26
Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest (1972) 1.26
Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome. Clin Exp Immunol (1977) 1.25